Cargando…
Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
Lack of clinically relevant tumor models dramatically hampers development of effective therapies for hepatocellular carcinoma (HCC). Establishment of patient-derived xenograft (PDX) models that faithfully recapitulate the genetic and phenotypic features of HCC becomes important. In this study, we fi...
Autores principales: | Gu, Qingyang, Zhang, Bin, Sun, Hongye, Xu, Qiang, Tan, Yexiong, Wang, Guan, Luo, Qin, Xu, Weiguo, Yang, Shuqun, Li, Jian, Fu, Jing, Chen, Lei, Yuan, Shengxian, Liang, Guibai, Ji, Qunsheng, Chen, Shu-Hui, Chan, Chi-Chung, Zhou, Weiping, Xu, Xiaowei, Wang, Hongyang, Fang, Douglas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652995/ https://www.ncbi.nlm.nih.gov/pubmed/26062443 |
Ejemplares similares
-
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
por: Yang, Shuqun, et al.
Publicado: (2015) -
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
por: Kissel, Maria, et al.
Publicado: (2017) -
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma
por: Shi, Yuanyuan, et al.
Publicado: (2022) -
Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study
por: Xu, Chang, et al.
Publicado: (2022) -
Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma
por: Qi, Yiming, et al.
Publicado: (2017)